| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Prodrug and antedrug: two diametrical approaches in designing safer drugs Lee HJ; Cooperwood JS; You Z; Ko DHArch Pharm Res  2002[Apr]; 25 (2): 111-36The prodrug and antedrug concepts, which were developed to overcome the physical  and pharmacological shortcomings of various therapeutic classes of agents, employ  diametrically different metabolic transformations. The prodrug undergoes a  predictable metabolic activation prior to exhibiting its pharmacological effects  in a target tissue while the antedrug undergoes metabolic deactivation in the  systemic circulation upon leaving a target tissue. An increased therapeutic index  is the aspiration for both approaches in designing as well as evaluation  criteria. The recent research endeavors of prodrugs include the gene-directed and  antibody-directed enzymatic activation of a molecule in a targeted tissue, organ  specific delivery, improved bioavailabilities of nucleosides and cellular  penetration of nucleotides. As for antedrugs, emphasis in research has been based  upon the design and synthesis of systemically inactive molecule by incorporating  a metabolically labile functional group into an active molecule.|*Drug Design[MESH]|Cytosine Deaminase[MESH]|Flucytosine/therapeutic use[MESH]|Ganciclovir/therapeutic use[MESH]|Genetic Therapy[MESH]|Immunoconjugates/therapeutic use[MESH]|Nucleoside Deaminases/genetics[MESH]|Nucleosides/therapeutic use[MESH]|Nucleotides/therapeutic use[MESH]|Prodrugs/*therapeutic use[MESH]|Thymidine Kinase/genetics[MESH]
 |